Altasciences & Evidence Matters Advance AI for Regulatory Writing
Altasciences, a totally built-in CRO/CDMO providing complete early-phase drug improvement options, is happy to announce a strategic collaboration with Proof Issues, a pioneer in medical trial knowledge science and doc engineering.
This partnership combines Altasciences’ real-world drug improvement experience with Proof Issues’ revolutionary, patent-pending Textual content Engineering know-how—a breakthrough that delivers near-deterministic accuracy in regulatory writing by decreasing variability and bettering the standard, consistency, and pace of documentation.
Proof Issues’ RegulatoryFlow platform (“RegFlow”) and specialised providers unify medical knowledge and paperwork, simplify workflows, and speed up the work of key life sciences professionals, from medical writers to regulatory specialists.
“We’re excited to work alongside Proof Issues to co-develop know-how that instantly enhances the standard and effectivity of regulatory writing,” mentioned Nicole Maciolek, Vice President, Analysis Companies at Altasciences. “By means of this partnership, we’re not simply implementing AI, we’re actively shaping its future as an indispensable instrument in life sciences.”
Altasciences is deeply engaged within the partnership, contributing real-world coaching knowledge and conducting person testing to assist make sure the know-how meets the wants of frontline groups. This collaboration underscores Altasciences’ ongoing dedication to leveraging synthetic intelligence to drive innovation, streamline complicated processes, and ship higher outcomes for each sponsors and sufferers.
“With Textual content Engineering, we’re shifting past automation into a brand new period of precision and consistency,” mentioned Dr. Ofer Avital, Founder and Director of Proof Issues. “The impression on regulatory documentation, from timelines to accuracy, is transformative. In testing in opposition to guide work, RegulatoryFlow demonstrated the elimination of desk switch errors that may contact roughly one-third of tables in life science regulatory paperwork, whereas decreasing TFL-to-Phrase processing time by greater than 50%.”
Dr. Avital additionally added, “Not like conventional enterprise platforms that require intensive implementation timelines, RegulatoryFlow integrates seamlessly with present Microsoft Phrase workflows, enabling speedy deployment in weeks relatively than months, and meets medical writers proper the place they work.”
Collectively, Altasciences and Proof Issues are redefining what’s potential in medical trial implementation and documentation, serving to sponsors transfer quicker, and with larger confidence, from candidate choice to medical proof of idea, and past.
The publish Altasciences & Evidence Matters Advance AI for Regulatory Writing first appeared on AI-Tech Park.